KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt repayments
Ratios

Emergent BioSolutions (EBS) Cost of Revenue (2016 - 2026)

Emergent BioSolutions has reported Cost of Revenue over the past 16 years, most recently at $72.0 million for Q1 2026.

  • For Q1 2026, Cost of Revenue fell 18.64% year-over-year to $72.0 million; the TTM value through Mar 2026 reached $309.7 million, down 18.31%, while the annual FY2025 figure was $326.2 million, 52.12% down from the prior year.
  • Cost of Revenue for Q1 2026 was $72.0 million at Emergent BioSolutions, down from $84.9 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $190.6 million in Q2 2023 and troughed at $900000.0 in Q1 2022.
  • A 5-year average of $110.1 million and a median of $88.5 million in 2025 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: tumbled 98.07% in 2022 and later skyrocketed 16888.89% in 2023.
  • Year by year, Cost of Revenue stood at $167.3 million in 2022, then rose by 10.64% to $185.1 million in 2023, then tumbled by 36.25% to $118.0 million in 2024, then decreased by 28.05% to $84.9 million in 2025, then dropped by 15.19% to $72.0 million in 2026.
  • Business Quant data shows Cost of Revenue for EBS at $72.0 million in Q1 2026, $84.9 million in Q4 2025, and $85.9 million in Q3 2025.